CIK 0001751912 · <br>Emerging growth company
NERVGEN PHARMA CORP.
Sign in to watch- Ticker
- NGEN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- other
- EIN
- 981738183
- Phone
- 7787311711
- Business address
- 112-970 BURRARD STREET, SUITE 1290, VANCOUVER, British Columbia, Canada, V6Z 2R4
- 40-F Report 40-F
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- S-8 Other Securities Offered to Employees in Benefit Plans
- 6-K Event Report of Foreign Issuer
- EFFECT Other Notice of Effectiveness
- CERT Other Certification
- 8-A12B Other Registration of Securities
- F-10/A Other F-10/A
- F-X Other F-X
- F-10 Other F-10
- D Other Notice of Sales of Unregistered Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
- D Other Notice of Sales of Unregistered Securities
Page 2 of 3 · 41 filings